 Andrew Wolf
Concepts (143)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 4 | 2024 | 487 | 1.220 |
Why?
| | Education, Nursing | 2 | 2018 | 91 | 1.010 |
Why?
| | Students, Nursing | 2 | 2018 | 92 | 0.990 |
Why?
| | Medical Tourism | 1 | 2023 | 9 | 0.790 |
Why?
| | Multiple Sclerosis, Relapsing-Remitting | 1 | 2024 | 82 | 0.750 |
Why?
| | Meningitis | 1 | 2023 | 80 | 0.720 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 110 | 0.690 |
Why?
| | Alzheimer Disease | 5 | 2016 | 629 | 0.660 |
Why?
| | Writing | 1 | 2022 | 101 | 0.650 |
Why?
| | Serum Sickness | 1 | 2019 | 4 | 0.610 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 339 | 0.560 |
Why?
| | Videotape Recording | 1 | 2018 | 37 | 0.560 |
Why?
| | Rituximab | 1 | 2019 | 210 | 0.560 |
Why?
| | Immunologic Factors | 1 | 2019 | 260 | 0.510 |
Why?
| | Superior Colliculi | 1 | 2015 | 44 | 0.440 |
Why?
| | Internet | 1 | 2018 | 689 | 0.400 |
Why?
| | Apolipoproteins E | 1 | 2012 | 93 | 0.370 |
Why?
| | Neuromyelitis Optica | 2 | 2024 | 140 | 0.360 |
Why?
| | Nutritional Physiological Phenomena | 1 | 2012 | 56 | 0.350 |
Why?
| | Mitochondrial Diseases | 1 | 2012 | 92 | 0.330 |
Why?
| | Models, Neurological | 1 | 2012 | 250 | 0.320 |
Why?
| | Motor Activity | 1 | 2015 | 718 | 0.320 |
Why?
| | Energy Metabolism | 2 | 2016 | 933 | 0.320 |
Why?
| | Strabismus | 2 | 2007 | 71 | 0.300 |
Why?
| | Decision Making | 1 | 2015 | 974 | 0.260 |
Why?
| | Dietary Supplements | 1 | 2012 | 582 | 0.260 |
Why?
| | Orbital Myositis | 1 | 2007 | 5 | 0.250 |
Why?
| | Oculomotor Muscles | 1 | 2007 | 86 | 0.240 |
Why?
| | Ophthalmologic Surgical Procedures | 1 | 2007 | 90 | 0.230 |
Why?
| | Albinism, Ocular | 1 | 2005 | 1 | 0.230 |
Why?
| | Albinism, Oculocutaneous | 1 | 2005 | 5 | 0.230 |
Why?
| | Nystagmus, Pathologic | 1 | 2005 | 19 | 0.220 |
Why?
| | Creutzfeldt-Jakob Syndrome | 1 | 2025 | 19 | 0.220 |
Why?
| | Human Growth Hormone | 1 | 2025 | 47 | 0.220 |
Why?
| | Aquaporin 4 | 1 | 2024 | 101 | 0.210 |
Why?
| | Apolipoprotein E4 | 2 | 2016 | 41 | 0.190 |
Why?
| | Gyrus Cinguli | 2 | 2016 | 96 | 0.190 |
Why?
| | Feedback | 1 | 2022 | 180 | 0.170 |
Why?
| | Humans | 20 | 2025 | 145140 | 0.160 |
Why?
| | Recurrence | 1 | 2024 | 1134 | 0.160 |
Why?
| | Brain | 1 | 2012 | 2934 | 0.160 |
Why?
| | Immunosuppressive Agents | 1 | 2024 | 837 | 0.140 |
Why?
| | Visual Acuity | 2 | 2016 | 491 | 0.140 |
Why?
| | Stem Cells | 1 | 2023 | 624 | 0.140 |
Why?
| | Faculty, Nursing | 1 | 2018 | 31 | 0.140 |
Why?
| | Education, Distance | 1 | 2018 | 59 | 0.130 |
Why?
| | Personal Satisfaction | 1 | 2018 | 218 | 0.120 |
Why?
| | Visual Cortex | 1 | 2016 | 84 | 0.120 |
Why?
| | Eye | 1 | 2016 | 112 | 0.110 |
Why?
| | Spatial Behavior | 1 | 2015 | 24 | 0.110 |
Why?
| | Neurosurgical Procedures | 2 | 2014 | 202 | 0.110 |
Why?
| | Vision Disorders | 1 | 2016 | 179 | 0.110 |
Why?
| | Electron Transport Complex IV | 2 | 2012 | 61 | 0.110 |
Why?
| | Learning | 1 | 2018 | 443 | 0.100 |
Why?
| | Neuroimaging | 1 | 2016 | 292 | 0.100 |
Why?
| | Postoperative Complications | 1 | 2007 | 2961 | 0.100 |
Why?
| | Oligodendroglioma | 1 | 2013 | 15 | 0.100 |
Why?
| | Neural Pathways | 1 | 2015 | 312 | 0.100 |
Why?
| | Evoked Potentials, Visual | 1 | 2013 | 42 | 0.100 |
Why?
| | Retinal Neoplasms | 1 | 2013 | 37 | 0.100 |
Why?
| | Retinoblastoma | 1 | 2013 | 42 | 0.100 |
Why?
| | Vision Screening | 1 | 2013 | 48 | 0.090 |
Why?
| | Pilot Projects | 1 | 2018 | 1889 | 0.090 |
Why?
| | Female | 12 | 2025 | 78636 | 0.090 |
Why?
| | Synaptophysin | 1 | 2012 | 15 | 0.090 |
Why?
| | Radionuclide Imaging | 1 | 2012 | 115 | 0.090 |
Why?
| | Maze Learning | 1 | 2012 | 105 | 0.090 |
Why?
| | Amyloidosis | 1 | 2012 | 44 | 0.090 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2013 | 337 | 0.090 |
Why?
| | Glial Fibrillary Acidic Protein | 1 | 2012 | 122 | 0.080 |
Why?
| | Aged | 5 | 2024 | 26096 | 0.080 |
Why?
| | tau Proteins | 1 | 2012 | 105 | 0.080 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2013 | 777 | 0.080 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2012 | 161 | 0.080 |
Why?
| | Radiopharmaceuticals | 1 | 2012 | 205 | 0.080 |
Why?
| | Glioblastoma | 1 | 2014 | 352 | 0.080 |
Why?
| | Genetic Carrier Screening | 1 | 2010 | 32 | 0.080 |
Why?
| | Plant Extracts | 1 | 2012 | 188 | 0.080 |
Why?
| | Retrospective Studies | 6 | 2024 | 17247 | 0.080 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 847 | 0.080 |
Why?
| | Neoplasms | 1 | 2024 | 2900 | 0.070 |
Why?
| | Psychomotor Performance | 1 | 2012 | 324 | 0.070 |
Why?
| | Radiosurgery | 1 | 2013 | 399 | 0.070 |
Why?
| | Reoperation | 2 | 2014 | 630 | 0.070 |
Why?
| | Treatment Outcome | 5 | 2024 | 11741 | 0.070 |
Why?
| | Immunohistochemistry | 1 | 2012 | 1713 | 0.070 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2014 | 1146 | 0.060 |
Why?
| | Prednisolone | 1 | 2007 | 67 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2016 | 2588 | 0.060 |
Why?
| | Male | 9 | 2024 | 72664 | 0.060 |
Why?
| | Sex Characteristics | 1 | 2012 | 775 | 0.060 |
Why?
| | Postoperative Period | 1 | 2007 | 351 | 0.060 |
Why?
| | Vision, Binocular | 1 | 2005 | 47 | 0.060 |
Why?
| | Iatrogenic Disease | 1 | 2025 | 74 | 0.050 |
Why?
| | Middle Aged | 5 | 2025 | 36126 | 0.050 |
Why?
| | Adult | 7 | 2024 | 40665 | 0.050 |
Why?
| | Brain Neoplasms | 1 | 2014 | 1328 | 0.050 |
Why?
| | Cadaver | 1 | 2025 | 311 | 0.050 |
Why?
| | Adolescent | 4 | 2024 | 22479 | 0.050 |
Why?
| | Cognition | 1 | 2012 | 1262 | 0.050 |
Why?
| | Mitochondria | 1 | 2010 | 992 | 0.050 |
Why?
| | Myelin-Oligodendrocyte Glycoprotein | 1 | 2023 | 55 | 0.050 |
Why?
| | Glucocorticoids | 1 | 2007 | 531 | 0.050 |
Why?
| | Genetic Predisposition to Disease | 1 | 2010 | 2351 | 0.040 |
Why?
| | Animals | 2 | 2015 | 37952 | 0.040 |
Why?
| | Mice, Inbred C57BL | 1 | 2012 | 5972 | 0.040 |
Why?
| | Inflammation | 1 | 2012 | 2876 | 0.040 |
Why?
| | United States | 3 | 2025 | 16065 | 0.040 |
Why?
| | Immunoglobulin G | 1 | 2023 | 887 | 0.030 |
Why?
| | Incidence | 1 | 2024 | 2915 | 0.030 |
Why?
| | Prevalence | 1 | 2024 | 2855 | 0.030 |
Why?
| | Young Adult | 3 | 2024 | 14176 | 0.030 |
Why?
| | Amino Acid Transport System X-AG | 1 | 2016 | 5 | 0.030 |
Why?
| | Tomography, X-Ray Computed | 1 | 2007 | 2767 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2016 | 21 | 0.030 |
Why?
| | Hexokinase | 1 | 2016 | 18 | 0.030 |
Why?
| | Disease Progression | 2 | 2014 | 2857 | 0.030 |
Why?
| | Autoantibodies | 1 | 2023 | 1508 | 0.030 |
Why?
| | Mice | 1 | 2012 | 18303 | 0.030 |
Why?
| | Tissue Fixation | 1 | 2013 | 37 | 0.030 |
Why?
| | Mitochondrial Proteins | 1 | 2016 | 263 | 0.030 |
Why?
| | Infusions, Intra-Arterial | 1 | 2013 | 61 | 0.020 |
Why?
| | Cryotherapy | 1 | 2013 | 21 | 0.020 |
Why?
| | Microsurgery | 1 | 2013 | 76 | 0.020 |
Why?
| | Risk Factors | 1 | 2007 | 10857 | 0.020 |
Why?
| | Hyperthermia, Induced | 1 | 2013 | 120 | 0.020 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2013 | 221 | 0.020 |
Why?
| | Meningioma | 1 | 2013 | 88 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2013 | 766 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2013 | 968 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 2013 | 286 | 0.020 |
Why?
| | Survival Analysis | 1 | 2013 | 1371 | 0.020 |
Why?
| | Combined Modality Therapy | 1 | 2013 | 1264 | 0.020 |
Why?
| | Child, Preschool | 1 | 2005 | 11835 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2803 | 0.020 |
Why?
| | Alleles | 1 | 2010 | 888 | 0.020 |
Why?
| | Child | 1 | 2005 | 22670 | 0.010 |
Why?
| | Prognosis | 1 | 2014 | 4310 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2013 | 5411 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2013 | 2207 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2014 | 8318 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2013 | 3892 | 0.010 |
Why?
| | Infant | 1 | 2013 | 10060 | 0.010 |
Why?
|
|
Wolf's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|